⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

September 15, 2025

Figure S1 from Transcriptome Analysis of Matched Cohorts of Long- and Short-term Survivors in Advanced High-grade Serous Tubo-ovarian Cancer

Sofya Marchenko Niklas Goernitz Wiebke A. Zoern Maria Joosten Inga Hoffmann Jalid Sehouli Gerald Niedobitek Carsten Denkert Bruno V. Sinn Svenja Kolb José Carbonell‐Caballero Alfonso Valencia Mihnea P. Dragomir Wolfgang Schmitt David Horst Elena Ioana Braicu Christine Sers Jonathan Pohl Eliane T. Taube

View Full Paper

Ask AI

Bookmark

Share

Key Points

The REMARK Diagram outlines the cohort construction for analyzing survivors' data in cancer research.
The Charité Cohort serves as a reference point for comparative survival analysis in high-grade serous tubo-ovarian cancer patients.
The figure is essential for understanding the methodologies and structures involved in cohort studies.
Transcriptional differences play a crucial role in differentiating between long- and short-term survivors in this study.

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Implication

Figure S1 illustrates the REMARK Diagram of cohort construction in advanced cancer survivors, indicating vital study design facets.

Abstract

Figure S1 shows a REMARK Diagram of the Charité Cohort construction.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Marchenko et al. (2025) studied this question.

synapsesocial.com/papers/68d4538731b076d99fa588f9 https://doi.org/10.1158/1078-0432.30125619

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Table S4 from Transcriptome Analysis of Matched Cohorts of Long- and Short-term Survivors in Advanced High-grade Serous Tubo-ovarian Cancer2025
2Figure S3 from Transcriptome Analysis of Matched Cohorts of Long- and Short-term Survivors in Advanced High-grade Serous Tubo-ovarian Cancer2025
3Figure S5 from Transcriptome Analysis of Matched Cohorts of Long- and Short-term Survivors in Advanced High-grade Serous Tubo-ovarian Cancer2025
4Figure S2 from Transcriptome Analysis of Matched Cohorts of Long- and Short-term Survivors in Advanced High-grade Serous Tubo-ovarian Cancer2025
5Figure S9 from Transcriptome Analysis of Matched Cohorts of Long- and Short-term Survivors in Advanced High-grade Serous Tubo-ovarian Cancer2025